NMPA

RSS

ViroMed clear to conduct head-to-head phase III VM-501 study

April 2, 2012

Phase III trials of human fibrinogen to commence in China

March 28, 2012

Calcium channel blocker for hypertension clear to enter clinical testing in China

March 14, 2012

Antisense Therapeutics to form joint venture for development of ATL-1102

Feb. 29, 2012

Ready-to-use oral therapy approved in China for oral mucositis in patients with cancer

Feb. 28, 2012

Milestone developments for Novartis' Lucentis and Galvus in China

Jan. 19, 2012

F-647 approved in China

Sep. 22, 2011

First iguratimod product approved in China

Aug. 26, 2011

High-dose EPIAO approved in China to treat chemotherapy-associated anemia

July 14, 2011

Chinese health authorities approve Novo Nordisk's Victoza for type 2 diabetes

March 16, 2011